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The Linear Ubiquitin chain Assembly Complex (LUBAC) is required for optimal gene activation 23 
and prevention of cell death upon activation of immune receptors, including TNFR11. Deficiency 24 
in the LUBAC components SHARPIN or HOIP in mice results in severe inflammation in 25 
adulthood or embryonic lethality, respectively, due to deregulation of TNFR1-mediated cell 26 
death2-8. In humans, deficiency in the third LUBAC component, HOIL-1, causes autoimmunity 27 
and inflammatory disease, similar to HOIP deficiency, whereas HOIL-1 deficiency in mice was 28 
reported to cause no overt phenotype9-11. By creating HOIL-1-deficient mice, we here show that 29 
HOIL-1 is, however, as essential for LUBAC function as HOIP, albeit for different reasons: 30 
whereas HOIP is LUBAC’s catalytically active component, HOIL-1 is required for LUBAC 31 
assembly, stability and optimal retention in the TNFR1-signalling complex (TNFR1-SC), thereby 32 
preventing aberrant cell death. Both, HOIL-1 and HOIP prevent embryonic lethality at mid-33 
gestation by interfering with aberrant TNFR1-mediated endothelial cell death, which only 34 
partially depends on RIPK1 kinase activity. Co-deletion of Caspase-8 with RIPK3 or MLKL 35 
prevents cell death in Hoil-1-/- embryos, yet only combined loss of Caspase-8 with MLKL results 36 
in viable HOIL-1-deficient mice. Interestingly, Ripk3-/-Caspase-8-/-Hoil-1-/- embryos die at late-37 
gestation due to haematopoietic defects that are rescued by co-deletion of RIPK1 but not MLKL. 38 
Collectively, these results demonstrate that both, HOIP and HOIL-1 are essential LUBAC 39 
components and are required for embryogenesis by preventing aberrant cell death. Furthermore, 40 
they unveil that, when LUBAC and Caspase-8 are absent, RIPK3 prevents RIPK1 from inducing 41 
embryonic lethality by causing defects in foetal haematopoiesis.  42 
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To determine the physiological role of HOIL-1, we generated HOIL-1-deficient mice by targeting exons 43 
1 and 2 of the Hoil-1 (Rbck1) gene (Extended Data Fig. 1a-d). No mice with homozygous deletion in 44 
the Hoil-1 gene were weaned (Fig. 1a). Analysis of Hoil-1-/- embryos revealed that they died around 45 
embryonic day (E) 10.5 (Fig. 1a, b). This result was confirmed with a strain generated from an 46 
independently targeted ES cell (C20Hoil-1-/- mice) (Extended Data Fig. 1e, f). At E10.5, Hoil-1-/- 47 
embryos presented with disrupted vascular architecture and cell death in the yolk sac endothelium (Fig. 48 
1c, d and Extended Data Fig. 1g, h), indicating that HOIL-1 absence causes aberrant endothelial cell 49 
death. Hoil-1fl/flTie2-Cre+ (endothelium/some haematopoietic cell-specific cre) embryos also died 50 
around E10.5 with the same abnormalities (Fig. 1e and Extended Data Fig. 1i, j). Loss of TNF or 51 
TNFR1 diminished cell death in the yolk sac and prevented lethality at E10.5 in Hoil-1-/- embryos (Fig. 52 
1f and Extended Data Fig. 2a-d). As in Tnfr1-/-Hoip-/-8, Tnfr1-/-Hoil-1-/- yolk sacs showed reduced cell 53 
death as compared to Hoil-1-/- embryos (Fig. 1f, g). Although cell death was not completely ablated in 54 
Tnfr1-/-Hoil-1-/- embryos, it did not appear to significantly affect yolk sac vasculature (Fig. 1f, g and 55 
Extended Data Fig. 2e). Nevertheless, Tnfr1-/-Hoil-1-/- embryos died around E16.5 (Extended Data 56 
Fig. 2d, f) with heart defects prior to death (Fig. 1h). Therefore, like HOIP, HOIL-1 is required to 57 
maintain blood vessel integrity by preventing TNFR1-mediated endothelial cell death during 58 
embryogenesis. 59 
 60 
To understand the role of HOIL-1 in LUBAC function, we compared TNFR1-SC formation in MEFs 61 
individually deficient for the LUBAC components. Whereas in SHARPIN-deficient MEFs TNFR1-SC-62 
associated linear ubiquitination was merely reduced7, it was completely absent in Tnf-/-Hoil-1-/- MEFs, 63 
exactly as in Tnf-/-Hoip-/- MEFs8 (Fig. 2a). In TNF-stimulated Tnf-/-Hoil-1-/- MEFs, NF-κB activation 64 
was attenuated (Extended Data Fig. 3a) and TNFR1 complex-II formation was enhanced (Fig. 2b), 65 
resulting in sensitisation to TNF-induced apoptosis and necroptosis (Fig. 2c). Hence, HOIL-1 is as 66 
essential as HOIP for linear ubiquitination within the TNFR1-SC. 67 
 68 
To determine whether the reduction in HOIP and SHARPIN protein levels in HOIL-1-deficient cells 69 
was responsible for the observed loss of linear ubiquitination (Fig. 2a), we reconstituted HOIL-1-70 
deficient MEFs with HOIP, with HOIP and SHARPIN, or, as a control, with HOIL-1. Reconstitution 71 
with HOIP, either alone or with SHARPIN, failed to restore LUBAC recruitment, linear ubiquitination 72 
at the TNFR1-SC, or optimal NF-κB activation. Furthermore, their reconstitution was unable to prevent 73 
TNF-induced complex-II formation and cell death (Fig. 2d-f and Extended Data Fig. 3b) whilst HOIL-74 
1 re-expression corrected all aforementioned defects (Fig. 2d-f and Extended Data Fig. 3b). In the 75 
absence of HOIL-1, HOIP was unable to bind to SHARPIN despite both being reconstituted to near 76 
endogenous levels (Extended Data Fig. 3c). Thus, HOIL-1 is required for LUBAC assembly and 77 
recruitment to the TNFR1-SC, identifying it as an essential component of LUBAC alongside HOIP. 78 
 79 
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To reveal how HOIL-1 enables LUBAC activity, we generated HOIL-1-deficient MEFs stably 80 
expressing full-length HOIL-1 (WT), the UBL domain of HOIL-1 only (HOIL-1-UBL), HOIL-1-81 
ΔRBR, HOIL-1-ΔUBL, HOIL-1 with inactivating mutations T201A/R208A in the NZF domain (HOIL-82 
1-NZFmut) or HOIL-1 with a point mutation in the catalytic cysteine of the RBR domain (HOIL-1-83 
C458A) (Fig. 2g). Except for HOIL-1-ΔUBL, all mutant HOIL-1 proteins bound to HOIP and 84 
SHARPIN and stabilised their levels (Fig. 2h). Isolation of the native TNFR1-SC revealed that HOIL-85 
1-ΔRBR and HOIL-1-C458A fully restored TNF-induced linear ubiquitination in HOIL-1-deficient 86 
cells, whereas HOIL-1-ΔUBL did not (Fig. 2i). HOIL-1-deficient cells expressing HOIL-1-UBL or 87 
HOIL-1-NZFmut only showed partial restoration of linear ubiquitination, correlating with reduced 88 
HOIP and SHARPIN levels at the TNFR1-SC (Fig. 2i). Thus, the UBL domain of HOIL-1 is essential 89 
for linear ubiquitination at the TNFR1-SC, whereas a functional NZF domain is required for optimal 90 
LUBAC presence in the TNFR1-SC. Expression of HOIL-1-ΔRBR restored optimal NF-κB signalling 91 
and prevented aberrant TNF-induced cell killing in contrast to HOIL-1-ΔUBL (Fig. 2j and Extended 92 
Data Fig. 3d). This observation elucidates why the previously reported mice, regarded as deficient for 93 
HOIL-1, are viable as they were generated by targeting exons 7 and 812, likely resembling the HOIL-1-94 
ΔRBR mutant studied here. Since the UBL of HOIL-1 binds to HOIP, allowing its activation13 and the 95 
NZF of HOIL-1 binds linear ubiquitin linkages14, our results provide evidence that HOIL-1 promotes 96 
HOIP activation as well as LUBAC assembly and recruitment to the TNFR1-SC via its UBL domain. 97 
Once linear ubiquitin chains are formed in the complex, the NZF domain of HOIL-1 promotes LUBAC 98 
retention by binding to these chains.  99 
 100 
Since both HOIL-1 and HOIP are equally important for LUBAC function and, consequently, for 101 
preventing aberrant cell death in vitro and in vivo, we used a genetic strategy to untangle the interplay 102 
between HOIL-1 or HOIP and the different cell death components. Inactivation of RIPK1 in Hoil-1-/- 103 
and Hoip-/- embryos delayed lethality until E14.5 (Fig. 3a and Extended Data Fig. 4a-d). At this time, 104 
Ripk1K45AHoil-1-/- and Ripk1K45AHoip-/- embryos had disrupted vascular architecture, excessive cell 105 
death in their yolk sacs, hearts, livers and lungs and presented with heart defects and liver necrosis (Fig. 106 
3b and Extended Data Fig. 4e-h). In accordance, TNFR1 complex-II formation and aberrant TNF/LT-107 
α-induced apoptosis were only partially inhibited in Ripk1K45AHoil-1-/- MEFs (Fig. 3c, d and Extended 108 
Data Fig. 4i). Thus, whilst the kinase activity of RIPK1 is essential for excessive TNFR1-induced cell 109 
death caused by attenuated LUBAC activity, as previously observed in SHARPIN-deficient mice4, this 110 
is not the case when LUBAC activity is completely abrogated. 111 
 112 
We next tested whether loss of RIPK3, MLKL or Caspase-8 could prevent lethality in Hoip-/- and Hoil-113 
1-/- embryos. At E10.5, Ripk3-/-Hoil-1-/- embryos presented with defects in vascularisation, excessive 114 
cell death and died at mid-gestation (Extended Data Fig. 5b, c). Due to the close chromosomal linkage 115 
of HOIP and RIPK3, we generated Mlkl-/-Hoip-/- mice (Extended Data Fig. 5a). These embryos also 116 
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died at mid-gestation (Extended Data Fig. 5d). Likewise, neither Caspase-8 heterozygosity nor 117 
Caspase-8 full deletion was sufficient to prevent the mid-gestation lethality of Hoip-/- and Hoil-1-/- 118 
embryos (Extended Data Fig. 5e, f and data not shown).  119 
 120 
As RIPK3-mediated necroptosis may be responsible for the embryonic lethality of Caspase-8+/-Hoil-1-121 
/- or Caspase-8-/-Hoil-1-/- mice15,16, we generated Ripk3-/-Caspase-8+/-Hoil-1-/- and Ripk3-/-Caspase-8-/-122 
Hoil-1-/- embryos and in both cases the lethality was delayed until around E14.5 (Fig. 3e and Extended 123 
Data Fig. 6a, b). At this developmental stage, a single intact copy of Caspase-8 was sufficient to induce 124 
apoptosis-driven loss of yolk sac vascularisation (Fig. 3f and Extended Data Fig. 6c, d). Yet, although 125 
Ripk3-/-Caspase-8-/-Hoil-1-/- embryos died around E14.5, yolk sac vascularisation was normalised and 126 
cell death in the yolk sac and other organs was prevented (Fig. 3f and Extended Data Fig. 6c-f). 127 
Moreover, Ripk3-/-Caspase-8-/-Hoil-1-/- MEFs were resistant to cell death induced by TNF or related 128 
cytokines (Extended Data Fig. 6g). Histological examination and microfocus CT scanning revealed 129 
the presence of heart defects in both Ripk3-/-Caspase-8-/-Hoil-1-/- and Ripk3-/-Caspase-8+/-Hoil-1-/- 130 
embryos (Extended Data Fig. 6h, i). We therefore conclude that whereas mid-gestation lethality in 131 
Hoil-1-/- embryos is dependent on Caspase-8/RIPK3-dependent apoptosis and necroptosis, Ripk3-/-132 
Caspase-8-/-Hoil-1-/- embryos die at late gestation by a process that is independent of cell death.  133 
 134 
In striking contrast to Ripk3-/-Caspase-8-/-Hoil-1-/- mice, both Mlkl-/-Caspase-8-/-Hoil-1-/- and Mlkl-/-135 
Caspase-8-/-Hoip-/- mice were born, albeit at lower than expected Mendelian ratios (Fig. 3g and 136 
Extended Data Fig. 7a). These mice were runted and had to be sacrificed by 4-5 weeks of age. 137 
Histopathological analysis revealed severe inflammation in the liver and lungs (Fig. 3h, Extended Data 138 
Fig. 7b-d and data not shown). Of note, Caspase-8 heterozygosity resulted in increased apoptosis of 139 
endothelial cells, causing lethality in both Mlkl-/-Caspase-8+/-Hoip-/- and Mlkl-/-Caspase-8+/-Hoil-1-/- 140 
embryos around E14.5 (Extended Data Fig. 7e and data not shown) indicating that Caspase-8-driven 141 
apoptosis is sufficient to cause death of LUBAC-deficient embryos. 142 
 143 
Co-deletion of RIPK3 and Caspase-8 causes embryonic lethality in otherwise viable cpdm mice7. 144 
However, Mlkl-/-Caspase-8-/-cpdm mice were viable and the inflammatory syndrome that characterises 145 
cpdm mice was prevented (Fig. 3i and Extended Data Fig. 7f, g), whilst expectedly17 developing 146 
lymphadenopathy and splenomegaly (Fig. 3i and Extended Data Fig. 7f). Thus, combined loss of any 147 
of the three LUBAC components together with loss of Caspase-8 uncovers a vital functional difference 148 
between RIPK3 and MLKL. 149 
 150 
We next evaluated whether the lethality of Ripk3-/-Caspase-8-/-Hoil-1-/- mice is due to aberrant (RIPK3-151 
independent) MLKL activation. This was particularly pertinent because MLKL levels were increased 152 
in Ripk3-/-Caspase-8-/-Hoil-1-/- embryos and MLKL was aberrantly activated in some of them 153 
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(Extended Data Fig. 7h). However, MLKL co-deficiency did not prevent the death of Ripk3-/-Caspase-154 
8-/-Hoil-1-/- embryos (Fig. 3j and Extended Data Fig. 7h). Thus, RIPK3 is required for survival of 155 
embryos in the absence of LUBAC by regulating an MLKL-independent process.  156 
 157 
To explore the nature of the pro-survival role of RIPK3, we performed RNAseq on E13.5 Ripk3-/-158 
Caspase-8-/-Hoil-1-/- and Mlkl-/-Caspase-8-/-Hoil-1-/- embryos and controls (Extended Data Fig. 8a and 159 
Supplementary Table 1). Gene Ontology (GO) enrichment analysis of differentially expressed genes 160 
pointed towards defects in erythropoiesis in Ripk3-/-Caspase-8-/-Hoil-1-/- embryos (Extended Data Fig. 161 
8b). Indeed, reduced levels of erythroid lineage Ter119+ cells (Fig. 4a), basophilic erythroblasts 162 
(Extended Data Fig. 8c) and mature erythrocytes (Fig. 4b) were observed in of Ripk3-/-Caspase-8-/-163 
Hoil-1-/- foetal livers. Furthermore, Ripk3-/-Caspase-8-/-Hoil-1-/- haematopoietic progenitors failed to 164 
differentiate into committed erythroid burst-forming units in culture (Fig. 4e). Further analysis of the 165 
haematopoietic compartment from E13.5 foetal livers revealed abnormally reduced percentages and 166 
total numbers of multipotent progenitors (Fig. 4d and Extended Data Fig. 8d, e) as well as leucocytes, 167 
including granulocytes and macrophages, and myeloid progenitors in the Ripk3-/-Caspase-8-/-Hoil-1-/- 168 
embryos compared to controls, whereas Mlkl-/-Caspase-8-/-Hoil-1-/- embryos had normal numbers of 169 
these cells (Extended Data Fig. 8f-k). In addition, the capacity of haematopoietic progenitors to 170 
generate colony-forming myeloid progenitors and multi-potent progenitors was also impaired in the 171 
Ripk3-/-Caspase-8-/-Hoil-1-/- embryos (Extended Data Fig. 8l). Accordingly, the viability of 172 
macrophages obtained from Ripk3-/-Caspase-8-/-Hoil-1-/- foetal liver cell suspensions in culture was 173 
significantly lower than those of controls and this could not be rescued by inhibiting necroptosis or 174 
apoptosis. Mlkl-/-Caspase-8-/-Hoil-1-/- foetal liver cells, however, produced normal numbers of 175 
macrophages (Extended Data Fig. 4m). Despite the heart defects of Ripk3-/-Caspase-8-/-Hoil-1-/- 176 
embryos, blood circulation was normal at E13.5 and the percentages of CD45+cKIT+ cells obtained 177 
from aorta-gonad-mesonephros regions were comparable between Ripk3-/-Caspase-8-/-Hoil-1-/- embryos 178 
and controls at E11.5 (Extended Data Fig. 8o, p). We therefore conclude that Ripk3-/-Caspase-8-/-Hoil-179 
1-/- embryos suffer from intrinsic defects in early haematopoiesis, likely downstream of specification in 180 
the aorta-gonad-mesonephros, resulting in substantial deficiencies in erythroid and myeloid cells. 181 
 182 
Since LUBAC is known to regulate RIPK124, we investigated the role of RIPK1 in the lethality of Ripk3-183 
/-Caspase-8-/-Hoil-1-/- embryos. Lethality of Ripk3-/-Caspase-8-/-Hoil-1-/- embryos was prevented by 184 
additional loss of RIPK1, despite RIPK1 levels being relatively low in Ripk3-/-Caspase-8-/-Hoil-1-/- 185 
embryos and RIPK1 deficiency failing to prevent Hoil-1-/- embryonic lethality (Fig. 4d, e and Extended 186 
Data Fig. 7h and 9a, b). Importantly, the viability of macrophages obtained from Ripk1-/-Ripk3-/-187 
Caspase-8-/-Hoil-1-/- foetal livers was comparable to controls (Extended Data Fig. 9c), indicating 188 
normalised haematopoiesis in these mice. The expression of several cytokines, including IL-1β, CCL2, 189 
IFN-β and CXCL10, was abnormally increased in Ripk3-/-Caspase-8-/-Hoil-1-/- embryos but not in Ripk1-190 
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/-Ripk3-/-Caspase-8-/-Hoil-1-/- embryos (Fig. 4f and Extended Data Fig. 9d, e). The function, survival, 191 
differentiation and self-renewal of haematopoietic progenitors are greatly impacted by various of these 192 
cytokines18,19. Therefore, our findings suggest that RIPK1-driven deregulated cytokine production in 193 
Ripk3-/-Caspase-8-/-Hoil-1-/- embryos may impair foetal haematopoiesis. Finally, treatment of pregnant 194 
females with the RIPK1 kinase inhibitor GSK'547A20 did not prevent lethality of Ripk3-/-Caspase-8-/-195 
Hoil-1-/- embryos, although it was able to extend the survival of Ripk3-/-Caspase-8+/-Hoil-1-/- embryos 196 
(Extended Data Fig. 9f). These results suggest that the lethality of Ripk3-/-Caspase-8-/-Hoil-1-/- embryos 197 
likely depends on the scaffolding function of RIPK1.  198 
 199 
Although RIPK1 is required for emergency haematopoiesis, RIPK1 might regulate embryonic 200 
haematopoiesis differently. Indeed, RIPK1-constitutive or haematopoietic-cell-specific-deficient mice 201 
are not embryonically lethal21,22. In addition, absence of LUBAC, RIPK3 and Caspase-8 might affect 202 
mechanisms during embryogenesis that are different from those perturbed by RIPK1 deficiency alone. 203 
Collectively, our findings imply that in the combined absence of LUBAC and Caspase-8, RIPK3 exerts 204 
a pro-survival role by regulating RIPK1-mediated signalling (Extended Data Fig. 10). Since Ripk3-/-205 
Caspase-8-/- mice are viable15,16,23, our findings indicate that control of RIPK1 by either LUBAC or 206 
RIPK3 is sufficient to enable proper haematopoiesis in the developing embryo, likely by preventing 207 
deregulated cytokine production. Thus, LUBAC and RIPK3 control RIPK1-mediated signalling to 208 
allow embryonic haematopoiesis.   209 
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Figure Legends 315 
 316 
Figure 1: HOIL-1 deficiency causes embryonic lethality at mid-gestation due to TNFR1-mediated 317 
endothelial cell death  318 
a, Mendelian frequencies obtained from inter-crossing Hoil-1+/- mice, *: dead embryos. b, 319 
Representative images of embryos from E9.5 to E11.5 quantified in (a), *: poor yolk sac vascularisation. 320 
Scale bar: 2 mm. c, Representative images of yolk sac vascularisation (PECAM-1, red) and cell death 321 
(cleaved (cl.) Caspase-3 staining, green) at E10.5 (top panel) (n=4 yolk-sacs/genotype), and whole-322 
mount TUNEL staining (bottom, panel) (n=2 yolk-sacs/genotype). Scale bar: 50 µm. d, g, 323 
Quantification of branching points (g) and cleaved Caspase-3 positive cells (g).  Mean ± s.e.m. values 324 
and P values from unpaired two-tailed t-tests are shown. e, Representative images of embryos at E10.5 325 
(n=14 Hoil-1fl/wtTie2-Cre+ and n=7 Hoil-1fl/flTie2-Cre+ embryos, top panel). *: poor yolk sac 326 
vascularisation. Scale bar: 2 mm. Yolk sac vascularisation (PECAM-1, red) and apoptosis (cleaved 327 
Caspase-3, green) (middle panel). Scale bar: 50 µm. Yolk sac whole-mount TUNEL staining (n=6 Hoil-328 
1fl/wtTie2-Cre+ and n=2 Hoil-1fl/flTie2-Cre+ yolk-sacs/genotype, bottom panel). f, Representative 329 
images of embryos at E15.5 (top panel, n=6 Tnfr1-/-Hoil-1-/- and n=19 Tnfr1-/-Hoil-1+/- embryos), scale 330 
bar: 2 mm, and yolk sac vascularisation (PECAM-1, red) and apoptosis (cleaved  Caspase-3, green) 331 
(bottom panel), Scale bar: 50 µm. h, Representative images of H&E staining on whole-embryo paraffin 332 
sections (n=3 embryos/genotype). *: pericardial effusion, arrows; congested vessels. H, heart; L, lung; 333 
Li, liver. Scale bar: 50 µm.  334 
 335 
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Figure 2: The UBL domain but not the RBR domain of HOIL-1 is essential for LUBAC activity 336 
at the TNFR1-SC and to prevent TNF/TNFR1-induced cell death. 337 
a, d, TNFR1-SC pull-down by FLAG- immunoprecipitation (IP) in MEFs derived from mice of the 338 
indicated genotypes ± FLAG-TNF for 15 min (n=2 independent experiments) (a) and reconstituted with 339 
HOIL-1, HOIP or HOIP and SHARPIN (n=4 independent experiments) (d). b, e, FADD-IP performed 340 
in MEFs of the indicated genotypes treated for 4 h with the caspase inhibitor zVAD-fmk ± TNF (b) and 341 
reconstituted as indicated (e) (n=2 independent experiments (b,e)). c, f, j, Cell death analysed by 342 
propidium iodide (PI) staining in MEFs with the indicated genotypes ± TNF ± the indicated inhibitors 343 
for 24 h (c), reconstituted (f) or transduced (j) as indicated (f, j). Mean ± s.e.m. (n=3 independent 344 
experiments) and P values from two-way ANOVA are shown. g, Schematic overview of HOIL-1 345 
constructs used to transduce Tnf-/-Hoil-1-/- MEFs. h, Flag-IP of indicated HOIL-1 mutants (n=2 346 
independent experiments). i, Endogenous TNFR1-SC pull-down by HA-IP in reconstituted Tnf-/-Hoil-347 
1-/- MEFs ± HA-TNF for 15 min (n=2 independent experiments). TL: total lysate, NT: not treated, EV: 348 
empty vector. For gel source data (a,b,d,e,h,i), see Supplementary Figure 1. 349 
 350 
Figure 3: Concomitant loss of MLKL and Caspase-8, but not loss of RIPK1 kinase activity or 351 
combined loss of RIPK3 and Caspase-8, promotes survival of LUBAC-deficient mice 352 
a, Representative images of E10.5 (n=6 embryos/genotype), scale bar: 2 mm, E14.5 (n=12 353 
Ripk1K45AHoil-1+/-, n=5 Ripk1K45AHoil-1-/- embryos/genotype) and E15.5 embryos (n=3 354 
embryos/genotype). Scale bar: 5 mm. *: poor yolk sac vascularisation. b, f, Representative images of 355 
yolk sac vascularisation (PECAM-1, red) and apoptosis (cleaved (cl.) Caspase-3, green) at E14.5 (b) or 356 
E13.5 (f) and quantification.  Mean ± s.e.m. and P values from unpaired two-tailed t-tests (b) or one-357 
way ANOVA (f) are shown. Scale bar: 50 µm. c, FADD-IP in MEFs treated for 3 h with zVAD-fmk ± 358 
TNF (n=2 independent experiments). For gel source data, see Supplementary Figure 1. d, Cell death by 359 
PI incorporation in MEFs ± TNF (10 ng/ml) or LT-α. Mean ± s.e.m. (n=3 independent experiments) 360 
and P values (****P<0.0001) from two-way ANOVA are reported. NT: not treated. e, Representative 361 
images of E14.5 (n=11 Ripk3-/-Caspase-8-/-Hoil-1+/-, Ripk3-/-Caspase-8+/-Hoil-1-/- and  n=7 Ripk3-/-362 
Caspase-8-/-Hoil-1-/-) and E15.5 embryos (n=5 Ripk3-/-Caspase-8-/-Hoil-1+/-, n=4 Ripk3-/-Caspase-8+/-363 
Hoil-1-/- and n=8 Ripk3-/-Caspase-8-/-Hoil-1-/-). *: poor yolk sac vascularisation. Scale bar: 5 mm. g, j, 364 
Mendelian frequencies obtained from inter-crossing Mlkl-/-Caspase-8+/-Hoil-1+/- with Mlkl-/-Caspase-8-365 
/-Hoil-1+/- mice (g) or Mlkl+/-Ripk3-/-Caspase-8-/-Hoil-1+/- with Mlkl-/-Ripk3-/-Caspase-8-/-Hoil-1+/- mice 366 
(top) or Mlkl-/-Ripk3-/-Caspase-8-/-Hoil-1+/- mice (bottom) (j). *: dead embryos. h, i, Representative 367 
images of adult mice quantified in (g) for (h) or n=3 mice/genotype in (i). m: cpdm mutation. 368 
 369 
Figure 4: Combined deletion of RIPK3 and Caspase-8 causes haematopoietic defects and RIPK1-370 
dependent embryonic lethality in HOIL-1-deficient mice. 371 
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a, b, Number (No.) of the TER119+ (erythroid) cells (a) and enucleated erythrocytes/high-power field 372 
(HPF) (b) in E13.5 foetal livers with the indicated genotypes. Mean ± s.e.m. and P values from unpaired 373 
two-tailed t-tests are shown. c, Differentiation of E13.5 foetal liver (c-KIT+) progenitors into burst 374 
forming units-erythrocyte (BFU-E). Mean ± s.e.m. and P values from unpaired two-tailed t-tests are 375 
reported. d, Percentage of haematopoietic progenitors negative for mature lineage markers (Lin-) and 376 
SCA-1+c-KIT+ (LSK) and SCA-1-c-KIT+ (LK) in E13.5 foetal livers with the indicated genotypes. 377 
Mean ± s.e.m. and P values from unpaired two-tailed t-tests are reported. e, Mendelian frequencies 378 
obtained from inter-crossing Ripk1-/-Ripk3-/-Caspase-8-/-Hoil-1+/- mice. f, Representative images of mice 379 
of the indicated genotypes quantified in (e). g, Cytokine levels in embryo homogenates with the 380 
indicated genotypes. Mean ± s.e.m and P values from one-way ANOVA are reported.  381 
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MATERIALS AND METHODS 382 
Mice  383 
The Hoil-1 floxed (Hoil-1fl/fl) mice were generated by a gene targeting strategy in ES cells in which the 384 
targeting cassette was composed of a hygromycin resistance cassette flanked by Frt sites and exons 1 385 
and 2 of the Hoil-1 gene flanked by loxP sites. Southern blots of C57BL/6 ES cell clones containing 386 
the homologous recombination were analysed for the specificity of the recombination and the absence 387 
of any unwanted integration. Two ES cell clones were used to generate mutant animals on the C57BL/6 388 
genetic background, corresponding to the two independent Hoil-1-/- strains (Hoil-1-/- and C20Hoil-1-/-). 389 
The hygromycin cassette was removed by crossing these mice with C57BL/6 mice expressing the FlpE 390 
recombinase and this was followed by a cross with C57BL/6 mice to remove the flpe transgene. Hoip-391 
/- and Hoil-1-/- mice were generated by crossing Hoipfl/fl, mice, previously described24, and Hoil-1fl/fl  392 
mice (described here) with transgenic mice expressing the loxP-deleter Cre recombinase (purchased 393 
from JAX: 6054, B6.C-Tg(CMV-Cre)1 Cgn/J). Transgenic mice expressing the Cre recombinase under 394 
the control of the Tie2 promoter (Tie2-Cre) (B6.Cg-Tg(Tek-cre)1Ywa/J)25 were used to delete floxed 395 
genes specifically in endothelial cells. C57BL/6 Mlkl-/- mice crossed to cpdm mice were previously 396 
described26. For all other crosses Mlkl-/- mice were generated using Transcription activator-like effector 397 
nuclease (TALEN). In brief, TALENs targeting exon 1 of the Mlkl gene were cloned via Golden-gate 398 
assembly. The RVD sequence of TAL1 against TACCGTTTCAGATGTCA was NI HD HD NN NG 399 
NG NG HD NI NN NI NG NN NG HD NI and TAL2 against TCGATCTTCCTGCTGCC was HD NN 400 
NI NG HD NG NG HD HD NG NN HD NG NN HD HD. Capped RNA was produced in vitro using 401 
mMESSAGE mMACHINE® T7 Transcription Kit (Ambion) and poly A tail was added using Poly(A) 402 
Tailing Kit (Ambion). Purified transcripts were mixed and adjusted to 25 ng/µL. C57BL/6 fertilised 403 
eggs were injected into both the cytoplasm and the pro-nucleus. Embryos were transferred into 404 
C57BL/6 pseudo-pregnant females. Pups were genotyped by sequencing using genomic DNA obtained 405 
from ear punches. One female carrying a 19 bp homozygous deletion causing a premature stop codon 406 
was selected for further breeding. Mlkl-/- mice were backcrossed to C57BL/6 mice for two generations. 407 
Sharpinm/m (C57BL/Ka, cpdm) and Tnfr1-/- (2818, B6.129-Tnfrsf1atm1Mak/J) mice were purchased 408 
from JAX. Tnf -/- mice (C57BL/6;129S6) were provided by William Kaiser. Ripk3-/- 27, Caspase-8-/- 28, 409 
Ripk1K45A 4 and Ripk1-/- 29 mice have been reported previously. Timed matings were performed as 410 
previously described8.  All mice were genotyped by PCR, fed ad libitum. All animal experiments were 411 
conducted under an appropriate UK project license in accordance with the regulations of UK home 412 
office for animal welfare according to ASPA (animal (scientific procedure) Act 1986). The relevant 413 
Animal Ethics Committee approved all experiments involving cpdm and the Ripk1-/- crosses which were 414 
maintained under appropriate licenses and subject to ethical review at The Walter and Eliza Hall 415 
Institute (Melbourne, Australia) and UT Health Sciences Center San Antonio (TX, USA), respectively. 416 
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Histological analysis, TUNEL and immunofluorescence staining  417 
Embryos or organs from adult mice were collected and fixed in 10% buffered formalin and paraffin 418 
embedded.  Sections of 4 µm were stained with haematoxylin and eosin following standard procedures. 419 
Necropsy of adult mice or six sagittal serial sections of two different planes of the embryo were used 420 
for blinded pathological analysis. For TUNEL staining, sections were treated according to the 421 
manufacturer’s instructions (DeadEnd™ Fluorometric TUNEL System, Promega, G3250). For whole 422 
mount TUNEL staining and immunofluorescence staining, samples were processed using the ApoTag 423 
plus Peroxidase In Situ Apoptosis Detection Kit (Millipore, S7101) according to the manufacturer’s 424 
instructions and as previously described8. Quantitation was performed by an experimenter blinded to 425 
the genotype of the mice by using ImageJ Software on monochrome images of the whole yolk sac by 426 
measuring the area of positive staining. Alternatively, TUNEL-positive cells were counted on five 427 
different fields (10x magnification). Yolk sacs were stained with antibodies against PECAM-1 (BD 428 
Biosciences, 5533370 Clone MEC13.3) and cleaved caspase-3 (Cell Signaling, 9664), followed by 429 
staining with secondary antibodies, Alexa Fluor 594 Goat anti-Rat IgG and Alexa Fluor 488 Goat anti-430 
Rabbit IgG (Invitrogen, A-11007 and A-11034, respectively), and analysed by fluorescent microscopy. 431 
Quantification was performed by an experimenter blinded to the genotype of the mice on ten different 432 
fields (10x magnification) per yolk sac. 433 
Microfocus CT scan 434 
Embryos were fixed in 4% paraformaldehyde and potassium triiodide (Lugol's iodine/I2KI, to impart 435 
tissue contrast), with a total iodine content of 63.25 mg/mL (iodine mass of 2.49 × 10−4 mol/mL), in a 436 
1:1 ratio for 8 h before imaging. Prior to scanning, the embryos were washed, wrapped in Parafilm M 437 
(Bemis, Oshkosh, WI, USA) and secured in 3% w/v Agar (Sigma-Aldrich, UK) within a low-density 438 
plastic cylinder to ensure mechanical stability during scan acquisition. Images were acquired using an 439 
XT H 225 ST microfocus-CT scanner with a multimetal target (Nikon Metrology, Tring, UK). Scans 440 
were reconstructed using modified Feldkamp filtered back projection algorithms with proprietary 441 
software (CTPro3D; Nikon Metrology) and post-processed using VG Studio MAX (Volume Graphics 442 
GmbH, Heidelberg, Germany). Soft tissues were analysed by Phong shading of direct volume 443 
renderings and plain projections and the vascular system by maximum intensity projections. 444 
Cells  445 
MEFs were isolated from E12.5-E13.5 embryos in accordance with standard procedures and these cells 446 
were maintained in DMEM medium supplemented with 10% foetal bovine serum (Sigma). 447 
Transformation was performed by lentiviral infection with the SV40 large T antigen. For reconstitution 448 
experiments, the coding sequence of murine HOIP, SHARPIN or HOIL-1 wild-type (WT), the UBL 449 
domain of HOIL-1 only (HOIL-1-UBL; AA 1-139), HOIL-1-ΔRBR (AA 1-252), HOIL-1-ΔUBL (AA 450 
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140-508), HOIL-1 with inactivating mutations T201A/R208A in the NZF domain (HOIL-1-NZFmut) 451 
or HOIL-1 with a point mutation in the catalytic cysteine of the RBR domain (HOIL-1-C458A) was 452 
inserted in MSCV vector followed by the internal ribosome entry site (IRES)-GFP sequence. These 453 
vectors were retrovirally transduced into MEFs and GFP-positive cells were sorted in a MoFlo 454 
cytometer (Beckman Coulter). 455 
Immunoprecipitation  456 
For isolation of the TNFR1-SC, transformed MEFs were stimulated with 3xFlag-2xStrep-TNF at 0.5 457 
μg/mL for 15 min, and controls were left untreated. Cells were subsequently solubilised in lysis buffer 458 
(30 mM Tris-HCl [pH 7.4], 150 mM NaCl, 2 mM EDTA, 2 mM KCl, 10% Glycerol, 1% Triton X-100, 459 
EDTA-free proteinase inhibitor cocktail (Roche, 5056489001) and 1x phosphatase-inhibitor cocktail 2 460 
(Sigma, P5726-1ML) at 4°C for 30 min. The lysates were cleared by centrifugation, and 3xFlag-461 
2xStrep-TNF (0.5 μg/mL/sample) was added to the untreated samples. Subsequently, the lysates were 462 
subjected to anti-Flag immunoprecipitation using M2 antibody coupled sepharose beads (Sigma, 463 
A2220-5ML) for 16 h. For FADD immunoprecipitation, transformed MEFs were treated with 20 μM 464 
zVAD-fmk (Abcam, ab120487) in the presence or absence of 100 ng/mL 6xHis-TNF for 3 h. Cells 465 
were lysed as described above and FADD was immunoprecipitated using anti-FADD antibody (Santa 466 
Cruz, sc-5559) and protein G Sepharose Beads (GE healthcare, 17-0618-01) at 4°C for 4 h. For Sharpin 467 
immunoprecipitation, anti-Sharpin antibody (ProteinTech, 14626-1-AP) was used. For all 468 
immunoprecipitations, the beads were washed three times with lysis buffer. Proteins were eluted in 50 469 
μL of LDS buffer (NuPAGE, Invitrogen) containing 50 mM DTT. Samples were analysed by Western 470 
blotting. 471 
Western blot analysis and antibodies 472 
Whole embryos were snap-frozen and homogenised in RIPA buffer (50 mM Tris pH 8.0, 150 mM 473 
NaCl, 0.5% sodium deoxycholate, 1% NP-40 and 1xEDTA-free proteinase inhibitor cocktail (Roche, 474 
5056489001) or RIPA buffer with 6M Urea for the experiment in Extended data Fig 7h. Alternatively, 475 
cells were washed twice with ice-cold PBS prior to lysis in lysis buffer. Protein concentration of lysates 476 
was determined using BCA protein assay (Thermo Scientific). Lysates were subsequently denatured in 477 
reducing sample buffer at 95°C for 10 min before separation by SDS-PAGE (NuPAGE) and subsequent 478 
analysis by Western blotting using antibodies against HOIL-130, HOIP (custom-made, Thermo Fisher 479 
Scientific), SHARPIN (ProteinTech, 14626-1-AP), TNFR1 (Abcam, ab19139), Actin (Sigma, A1978), 480 
pIκBα (Cell Signaling, 9246), IκBα (Cell Signaling, 9242), cleaved caspase-8 (Cell Signaling, 9429), 481 
linear ubiquitin (Merck Millipore, MABS199), RIPK1 (BD, 610459), RIPK3 (Enzo, ADI-905-242-482 
100), FADD (Assay Design, AAM-121), MLKL (Millipore, MABC604),  phospho-MLKL (Abcam, 483 
ab196436) and Tubulin (Sigma, T9026). 484 
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Cell death analysis by PI staining 485 
Cells were seeded to 80% confluence and were then incubated with 100 ng/mL His-tagged TNF, 1 486 
ug/mL CD95L-Fc, 1 µg/mL isoleucine zipper tagged murine TRAIL (iz-mTRAIL), 100 µg/mL 487 
Poly(I:C) HMW (InvivoGen, tlrl-pic), 20 ng/mL IFN-γ (Peprotech, 315-05) or 100 ng/mL LT-α 488 
(Thermo Fisher Scientific, 10270-HNAE) for 24 h, unless otherwise indicated. When indicated the 489 
following inhibitors were used: 20 µM Z-VAD-FMK (Abcam, ab120487), 10 µM Necrostatin-1s 490 
(Biovision, 2263-5). Supernatants and adherent cells were harvested and resuspended in PBS containing 491 
5 μg/mL propidium iodide (PI). PI-positive cells were enumerated by FACS (BD Accuri). 492 
RNA sequencing analysis  493 
E13.5 embryos were snap frozen and RNA was prepared using the RNeasy minikit (Qiagen, 74104) 494 
according to the manufacturer’s instruction. To generate the library, samples were processed using the 495 
KAPA mRNA HyperPrep Kit (p/n KK8580) according to the manufacturer’s instructions. Briefly, 496 
mRNA was isolated from total RNA using Oligo dT beads to pull down poly-adenylated transcripts. 497 
The purified mRNA was fragmented using chemical fragmentation (heat and divalent metal cation) and 498 
primed with random hexamers.  Strand-specific first strand cDNA was generated using Reverse 499 
Transcriptase in the presence of Actinomycin D.  The second cDNA strand was synthesised using dUTP 500 
in place of dTTP, to mark the second strand. The resultant cDNA was then “A-tailed” at the 3’ end to 501 
prevent self-ligation and adapter dimerisation. Truncated adaptors, containing a T overhang were 502 
ligated to the A-Tailed cDNA. Successfully ligated cDNA molecules were then enriched with limited 503 
cycle PCR. Libraries to be multiplexed in the same run were pooled in equimolar quantities, calculated 504 
from Qubit and Bioanalyser fragment analysis. Samples were sequenced on the NextSeq 500 instrument 505 
(Illumina, San Diego, US) using a 43bp paired end run. Run data were de-multiplexed and converted 506 
to fastq files using Illumina’s bcl2fastq Conversion Software v2.18 on BaseSpace.  Fastq files were 507 
then aligned to a reference genome using STAR on the BaseSpace RNA-Seq alignment app v1.1.0. 508 
Reads per transcript were counted using HTSeq and differential expression was estimated using the 509 
BioConductor package DESeq2 (BaseSpace app v1.0.0).  Next, 4 groups of differentially regulated 510 
genes were analysed: low and high abundance Ripk3-/-Caspase-8-/-Hoil-1+/-  versus Mlkl-/-Caspase-8-/-511 
Hoil-1+/-  embryos and low and high abundance in Ripk3-/-Caspase-8-/-Hoil-1-/- versus Mlkl-/-Caspase-8-512 
/-Hoil-1-/- embryos. To identify genes that were specifically altered in the absence of HOIL-1, the Venny 513 
2.1 software was used to exclude genes that were differentially expressed between Ripk3-/-Caspase-8-/-514 
Hoil-1+/- and Mlkl-/-Caspase-8-/-Hoil-1+/- embryos from those between Ripk3-/-Caspase-8-/-Hoil-1-/- and 515 
Mlkl-/-Caspase-8-/-Hoil-1-/- embryos. Genes that were already differentially expressed between the 516 
corresponding HOIL-1-expressing controls (i.e. Ripk3-/-Caspase-8-/-Hoil-1+/- and Mlkl-/-Caspase-8-/-517 
Hoil-1+/- embryos) were excluded from the differentially expressed genes between Ripk3-/-Caspase-8-/-518 
Hoil-1-/- and Mlkl-/-Caspase-8-/-Hoil-1-/- embryos. The resulting list of genes (33/85, dark green) was 519 
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entered in the STRING software (string-db.org) to assess for functional enrichment in biological 520 
networks. Gene ontology (GO) terms with false discovery rate (FDR) below 1% are shown.  521 
Flow Cytometry analysis (FACS), colony forming unit assay and macrophage culture  522 
For phenotypic analysis, single-cell suspensions from mechanically dissociated E13.5 foetal livers or a 523 
pool of aortas (AGM region) from 3 embryos, were stained for 30 min on ice with various antibody 524 
cocktails. The antibodies against the surface markers examined were: CD16/32, clone 93 and 2.4G2 525 
(eBioscience, 45-0161-82 and BD553141), CD135, clone A2F10.1 (BD, 553842), Ly-6A/E, clone D7 526 
(Sca-1) (BD, 558162), CD117 (c-Kit), clone 2B8 (BD, 560185), CD34, clone RAM34 (BD, 562608), 527 
mouse Lineage Cocktail, clones 17A2/RB6-8C5/RA3-6B2/Ter-119/M1/70 (Biolegend, 133313 and 528 
BD, 561301), CD16/32, clone 2.4G2 (BioXcell, CUS-HB-197), CD11b, clone M1/70 (Biolegend, 529 
101228 and eBioscience, 15-0112-81), CD11c, clone HL3 (BD, 561241), F4/80, clone BM8 530 
(Biolegend, 123110), GR-1, clone RB6-8C5 (Biolegend, 108416 and 108410), CD45, clone 30-F11 531 
(Biolegend, 103128 and Biolegend, 103112), CD3ε, clone, 145-2C11 (Biolegend, 100310), B220, clone 532 
RA3-6B2, (Biolegend, 103210), CD71, clone RI7217 (Biolegend, 113807), TER-119, clone TER-119 533 
(Biolegend, 116234) and Fixable Viability Dye (eBioscience, 65-0864-18 and 65-0867-14). The 534 
myeloid progenitors were identified in the LK population as CD34+CD16/32- (CMP), CD34+CD16/32+ 535 
(GMP); CD34-CD16/32- (MEP) Fluorescence minus one (FMO) were used as a gating control. For 536 
quantification of absolute number of cells, a defined number of flow cytometric reference beads 537 
(Invitrogen) were mixed with the samples before acquisition. Samples were processed either using LSR 538 
Fortessa (BD Biosciences) or sorted in a FACSAria FUSION cell sorter (BD Biosciences). Data were 539 
analysed with FlowJo 7.6.1 software (Treestar). Cytospin preparations of 10.000 cells/slide of E13.5 540 
foetal liver homogenates were stained by May-Grunwald Giemsa staining and enucleated erythrocytes 541 
were quantified blindly as number of cells per HPF using ImageJ Software. For growth of primitive 542 
erythroid progenitor cells or all haematopoietic stem cells, 5000 sorted Lineage-c-KIT+ E13.5 liver cells 543 
were cultured in MethoCult™ SF containing cytokines, including EPO (Stem Cell, M3436) or Mouse 544 
Methylcellulose Complete Media (R&D, HSC007), respectively. Colonies were enumerated after 14 545 
days of incubation. For preparation of foetal liver-derived macrophages, equal amounts of E13.5 single 546 
cell suspensions were cultured and differentiated for 5 days in DMEM supplemented with 10% FCS 547 
plus 20% L929-conditioned medium (as a source of M-CSF) supplemented or not with the indicated 548 
inhibitors. Cells were imaged using EVOS Auto cell imaging system and viability was measured using 549 
the CellTiter-Glo® Luminescent Cell Viability Assay (Promega, G7572). Alternatively, cells were 550 
stained with Hoechst dye and enumerated using Citation cell imaging platform.  551 
Cytokine analysis 552 
Embryo homogenates prepared as described above (Western blot and antibodies) were analysed with 553 
Proteome Profiler Arrays (Mouse Angiogenesis Array, ARY015, and Mouse Cytokine array Panel A, 554 
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ARY006 both R&D). ELISA kits used were the CXCL4 (R&D, DY595), CXCL11 (Abcam, ab204519), 555 
CXCL10 (R&D, DY466-05), IFN Lambda 2/3 (Pbl assay science, 62830-1), IL-1β (ThermoFisher, 556 
BMS6002) and IFN-β ELISA (ThermoFisher, 424001). 557 
Epidermal thickness quantification 558 
Per mouse, 1-2 pieces of skin were taken and epidermal thickness was measured by microscopy using 559 
a 20x magnification. Quantification was performed by an experimenter blinded to the genotype of the 560 
mice by using the CellSens software with at least 20 measurements per mouse. 561 
Pharmacological inhibition of RIPK1 kinase activity 562 
Mice were fed with rodent chow containing 100 mg/kg of the RIPK1 kinase inhibitor GSK3540547A 563 
(GSK’547A) (GlaxoSmithKline LLC) starting a week prior to mating and kept on this diet throughout 564 
pregnancy until cesarean section at the indicated time points. 565 
Statistics and reproducibility 566 
Group size was determined based on preliminary data sets. Statistical significance was determined using 567 
unpaired, two-tailed parametric Student’s t-test. One- or two-way ANOVA with Tukey’s multiple 568 
comparisons test was applied. 95% Confidence interval was considered for statistics and P-values (P) 569 
of <0.05 was considered significant and indicated with *P<0.05, **P<0.01, ***P<0.001 and 570 
****P<0.0001. Multiplicity adjusted P values are reported for multiple comparisons. All statistical 571 
analyses were performed using Graphpad Prism 6. Statisical transformations for RNAseq was 572 
performed with DESeq2 and adjusted P values utilised the Benjamini Hochberg test. All in vitro 573 
experiments were performed at least twice with similar results. Unless indicated in figure legends in 574 
vivo experiments were performed with at least 2 embryos per genotype. At least 3 embryos were 575 
considered for statistical testing.  576 
Data availability statement 577 
Additional information on this manuscript can be found in the Extended Data files, Supplementary 578 
Figure 1 and Source Data (gels and graphs). RNA sequencing analysis data is available from SRA 579 
database SRP134865 (BioProject ID: PRJNA437851) and comparative data sets including genes 580 
differentially regulated genes between embryo homogenates with different mutations are displayed in 581 
Supplementary Table 1.  582 
  583 
19 
 
Extended Data Figure Legends 584 
 585 
Extended data Figure 1. HOIL-1-deficient mice die at mid-gestation 586 
a, Schematic representation of the Hoil-1 knockout strategy. Solid boxes represent Hoil-1 exons and 587 
grey boxes with a star indicate the targeted exons. Boxes with diagonal and horizontal strips represent 588 
LoxP and Frt sites, respectively. b, Specificity of gene recombination was assessed by Southern blotting 589 
with 5’ and 3’ probes external to the construct in four clones (14B8, 14F6, 20D7 and 21F7). Digest of 590 
the DNA with ApaI, followed by hybridisation with the 3’ probe was expected to show a 5700 bp band 591 
for the WT allele and a 7700 bp band for the mutant allele. All four clones appeared to have the correct 592 
recombination on the 3’ side. Digest of the DNA with SphI and hybridisation with the 5’ probe was 593 
expected to show a 4500 bp WT band and a 6200 bp band for the mutated allele. Clones 14B8, 14F6 594 
and 21F7 appeared to be correctly recombined on the 5’ side. Finally, cutting the DNA with ApaI and 595 
hybridising with a hygro probe showed a single band in all clones, indicative of a single integration of 596 
the construct in all four ES clones. Clones 14B8 and 14F6 were selected for generation of the two Hoil-597 
1-/- strains. c, PCR analysis of Hoil-1 wild-type, heterozygous and knockout mice. d, Protein levels of 598 
HOIL-1, HOIP and SHARPIN in whole embryo lysates (n= 3 for Hoil-1+/- and Hoil-1-/- embryos and 599 
n=1 for Hoil-1+/+ embryos). For gel source data (c, d), see Supplementary Figure 1. e, Quantification of 600 
genotypes of animals obtained from inter-crossing C20Hoil-1+/- mice. *indicates dead embryos. f, 601 
Representative images of C20Hoil-1+/- and C20Hoil-1-/- embryos from E9.5 to E11.5 as quantified in 602 
(e). Scale bar: 2 mm. g, Single staining showing vascularisation (PECAM-1, top panel) and apoptosis 603 
(cleaved Caspase-3, bottom panel) of yolk sacs. Merged image is shown in Fig. 1c. h, Whole-mount 604 
TUNEL staining of embryos at the indicated stages (embryo/genotype n=2 at E10.5, n=8 for Hoil-1+/- 605 
and n=5 for Hoil-1-/- at E11.5). Scale bar: 2 mm. i, Quantification of genotypes of animals obtained 606 
from inter-crossing Hoil-1fl/wtTie2-Cre+ with Hoil-1fl/flTie2-Cre- mice. *indicates dead embryos. j, 607 
Representative images of embryos with conditional deletion of Hoil-1 in Tie2-Cre expressing cells as 608 
quantified in (i). Scale bar: 2 mm. *: poorly vascularised yolk sac.  609 
 610 
Extended data Figure 2. TNFR1 signalling drives cell death and lethality of HOIL-1-deficient 611 
mice at mid-gestation. 612 
a, d, Quantification of genotypes of animals obtained from inter-crosses of Tnf-/-Hoil-1+/- (a) and Tnfr1-613 
/-Hoil-1+/- (d) mice. *: dead embryos. b, Representative images of embryos quantified in (a) at E10.5 614 
and E15.5, *; poor yolk sac. c, Cell death as detected by whole-mount TUNEL staining in yolk sacs at 615 
E10.5 (n= 3 embryos/genotype). e, Single staining showing vascularisation (PECAM-1, top panel) and 616 
apoptosis (cleaved Caspase-3, bottom panel) of yolk sacs. Merged image is shown in Fig. 1g. Scale bar: 617 
50 µm. f, Representative images of embryos at E16.5 (n=2 for Tnfr1-/-Hoil-1+/- and n=4 for Tnfr1-/-Hoil-618 
1-/-).  619 
 620 
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Extended data Figure 3. HOIL-1 is required for optimal TNF-induced NF-kB activation 621 
independently of its RBR domain.  622 
a, b, d, Western blot analysis of the indicated proteins in whole-cell lysates from MEFs of the indicated 623 
genotypes after they had been stimulated with TNF (or left untreated) for the indicated time points in 624 
minutes (min) (a), overexpressing the different LUBAC components (b) or the indicated mutant forms 625 
of HOIL-1 (d) (n=2 independent experiments). c, SHARPIN-IP was performed in Tnf-/-Hoil-1-/- MEFs 626 
reconstituted with HOIL-1 or a combination of HOIP and SHARPIN and analysed by Western blotting 627 
(n=2 independent experiments). TL: total lysate, EV: empty vector. For gel source data, see 628 
Supplementary Figure 1. 629 
 630 
Extended data Figure 4. Ablation of the kinase activity of RIPK1 in HOIL-1- or HOIP-deficient 631 
embryos prevents cell death and lethality at mid-gestation but not at late gestation.  632 
a, b, Quantification of genotypes of animals obtained after inter-crossing Ripk1K45AHoil-1+/- (a) and 633 
Ripk1K45AHoip+/- (b) mice. *indicates dead embryos. c, Representative images of embryos quantified in 634 
(b) *; poor yolk sac vascularisation. Scale bar: 2 mm. d, Whole-mount TUNEL staining of embryos 635 
(n=2 embryos). Scale bar: 2 mm. e, Single staining showing vascularisation (PECAM-1, top panel) and 636 
apoptosis (cleaved (cl.) Caspase-3, bottom panel) of yolk sacs. Merged image is shown in Fig. 3b. f, g, 637 
Representative images of cell death in different organs (f) and quantification (g) as detected by TUNEL 638 
staining at E14.5 (n=3 embryos/genotype). Scale bar: 50 μm (f). Mean ± s.e.m. (n=3 embryos/genotype) 639 
and P values from one-way ANOVA are reported (g). h, Representative images of H&E staining on 640 
whole-embryo paraffin sections (n=3 embryos/genotype). *; pericardial effusion, n, necrotic area. H, 641 
heart; L, lung; Li, liver. Scale bar: 200 µm. i, Cell death was analysed by PI staining in MEFs stimulated 642 
or not with TNF for 24 h plus the indicated cell death inhibitors. Mean ± s.e.m. (n=3 independent 643 
experiments) and P values from two-way ANOVA are reported.  644 
  645 
Extended data Figure 5. Individual deletion of mediators of apoptosis or necroptosis does not 646 
prevent cell death and lethality at mid-gestation of HOIL-1- or HOIP-deficient embryos.  647 
a, Western blot analysis of MLKL expression in the indicated organs derived from control Mlkl-/- mice 648 
(n=2 mice/genotype). For gel source data, see Supplementary Figure 1. b, d, e, f,  Representative images 649 
of embryos at different stages of gestation (E10.5: n=7 for Ripk3-/-Hoil-1+/- and n=5 for Ripk3-/-Hoil-1-/-650 
; E11.5: n=5 for Ripk3-/-Hoil-1+/- and n=2 for Ripk3-/-Hoil-1-/-; E12.5: n=9 for Ripk3-/-Hoil-1+/- and n=2 651 
for Ripk3-/-Hoil-1-/- (b), E10.5: n=16 for Mlkl-/-Hoip+/- and n=6 for Mlkl-/-Hoip-/-; E11.5: n=8 for Mlkl-/-652 
Hoip+/- and n=6 for Mlkl-/-Hoip-/-; E12.5: n=10 for Mlkl-/-Hoip+/- and n=5 for Mlkl-/-Hoip-/- (d), E10.5: 653 
n=5 for Caspase-8+/-Hoip+/- and n=4 for Caspase-8+/-Hoip-/-; E11.5: n=6 for Caspase-8+/-Hoip+/- and 654 
n=3 for Caspase-8+/-Hoip-/-; E12.5: n=3 for Caspase-8+/-Hoip+/- and n=2 for Caspase-8+/-Hoip-/- (e), 655 
E10.5: n=2 for Caspase-8+/-Hoil-1+/- and n=4 for Caspase-8+/-Hoil-1-/-; E11.5: n=2 for Caspase-8+/-656 
Hoil-1+/- and n=5 for Caspase-8+/-Hoil-1-/-; E12.5: n=6 for Caspase-8+/-Hoil-1+/- and n=3 for Caspase-657 
21 
 
8+/-Hoil-1-/- (f)). *: poor yolk sac vascularisation. Scale bar: 2 mm. c, Representative images of yolk sac 658 
vascularisation and cell death at E10.5 as detected by PECAM-1 (red) and cleaved (cl.) Caspase-3 659 
staining (green) (top panel) and whole mount TUNEL staining (bottom panel) (n=4 per genotype). Scale 660 
bar: 50 µm.  661 
 662 
Extended data Figure 6. Combined deletion of RIPK3 and Caspase-8 prevents cell death but not 663 
embryonic lethality at late gestation that is caused by the loss of HOIL-1. 664 
a, Quantification of genotypes of animals obtained from inter-crosses of Ripk3-/-Caspase-8+/-Hoil-1+/- 665 
with Ripk3-/-Caspase-8-/-Hoil-1+/- mice (left panel) or Ripk3-/-Caspase-8-/-Hoil-1+/- mice (right panel). b, 666 
Health status of Ripk3-/-Caspase-8+/-Hoil-1-/- and Ripk3-/-Caspase-8-/-Hoil-1-/- embryos at different 667 
developmental stages. c, Single staining showing vascularisation (PECAM-1, top panel) and apoptosis 668 
(cleaved (cl.) Caspase-3, bottom panel) of yolk sacs. Merged image is shown in Fig. 3f. Scale bar: 50 669 
µm. d, Cell death as detected by whole-mount TUNEL staining in yolk sacs at E14.5 (left panel) and 670 
respective quantification (right panel). Mean ± s.e.m. (n=3 embryos/genotype) and P values from one-671 
way ANOVA are reported. e, f Representative images (e) and quantification (f) of cell death in different 672 
organs as detected by TUNEL staining at E13.5 (n=3 embryos/genotype) and E14.5 (n=5 for Ripk3-/-673 
Caspase-8-/-Hoil-1+/-, n=2 for Ripk3-/-Caspase-8-/-Hoil-1-/- and Ripk3-/-Caspase-8-/-Hoil-1-/- lung and 674 
liver and n=3 Ripk3-/-Caspase-8-/-Hoil-1-/- heart). Scale bar: 50 µm (e). Mean ± s.e.m. values are shown 675 
(f). g, Cell death was analysed by PI staining in MEFs stimulated or not with the indicated ligands for 676 
24 h. Mean ± s.e.m. (n=3 independent experiments) and P values from two-way ANOVA are reported. 677 
h, Representative images of H&E staining on E13.5 whole-embryo paraffin embedded sections (n=3 678 
for Ripk3-/-Caspase-8-/-Hoil-1+/- and Ripk3-/-Caspase-8-/-Hoil-1-/- and n=2 for Ripk3-/-Caspase-8+/-Hoil-679 
1-/-). *: pericardial effusion, arrows; congested vessels H, heart; L, lung; Li, liver. Scale bar: 200 µm. i, 680 
Representative images of micro-focus CT scan images of whole E13.5 embryos (n=3 681 
embryos/genotype). *: pericardial effusion 682 
 683 
Extended data Figure 7. Combined deletion of MLKL and Caspase-8 promotes survival of 684 
LUBAC-deficient mice.  685 
a, Quantification of genotypes of animals obtained from inter-crosses of Mlkl-/-Caspase-8+/-Hoip+/- with 686 
Mlkl-/-Caspase-8-/-Hoip+/-  mice. *: dead embryos. b, Representative images of adult mice as quantified 687 
in (a). c, Kaplan-Meier plot of mouse survival (n=6 for Mlkl-/-Caspase-8-/-Hoip-/- and n=9 for Mlkl-/-688 
Caspase-8-/-Hoil-1-/- mice). d, Representative images of H&E staining of the indicated organs (n=3 689 
mice/genotype). Scale bar: 200 µm. e, Representative images of yolk sac vascularisation (PECAM-1, 690 
red) and apoptosis (cleaved (cl.) Caspase-3, green) (top panel) at E13.5 and respective quantifications 691 
(bottom panel). Mean ± s.e.m (n=5 for Mlkl-/-Caspase-8-/-Hoil-1+/- and Mlkl-/-Caspase-8-/-Hoil-1-/- and 692 
n=2 for Mlkl-/-Caspase-8+/-Hoil-1-/-) are shown and results were analysed with unpaired two-tailed t-693 
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tests comparing Mlkl-/-Caspase-8-/-Hoil-1+/- and Mlkl-/-Caspase-8-/-Hoil-1-/- embryos. f, Representative 694 
images of H&E staining of the indicated organs (n=3 embryos/genotype). Scale bar: 200 µm. g, 695 
Epidermal thickness quantification of mice of the indicated genotypes in (f). Mean ± s.e.m values (n=3 696 
mice/genotype) are shown and results were analysed with unpaired two-tailed t-tests. h, Western blot 697 
analysis of lysates from whole E13.5 embryos of the indicated genotypes as well as L929 cells treated 698 
or not with TNF plus zVAD-fmk for 2 h as antibody validation (n=4 embryos/genotype performed 699 
twice). For gel source data, see Supplementary Figure 1. 700 
 701 
Extended data Figure 8. Combined deletion of RIPK3 and Caspase-8 causes haematopoietic 702 
defects and RIPK1-dependent embryonic lethality in HOIL-1-deficient mice.  703 
a, Venn diagram depicting genes differentially expressed by RNAseq analysis between E13.5 embryos 704 
of the indicated genotypes. b, Gene Ontology (GO) enrichment analysis of differentially (85 low and 705 
35 high in (a)) expressed genes. FDR: false discovery rate .c, Representative FACS profile of E13.5 706 
foetal liver cells with different erythroblast populations gated according to their CD71 and TER119 707 
expression levels (R1-R5). R1 contains immature RBC progenitors, including BFU-E and CFU-E; R2 708 
comprises mainly pro-erythroblasts and early basophilic erythroblasts; R3 contains both early and late 709 
basophilic erythroblasts; R4 is composed of chromatophilic and orthochromatophilic erythroblasts; and 710 
R5 consists of late orthochromatophilic erythroblasts and reticulocytes and quantification. Mean ± 711 
s.e.m. (n=14 Ripk3-/-Caspase-8-/-Hoil-1+/-, n=8 Ripk3-/-Caspase-8-/-Hoil-1-/-, n=5 for Mlkl-/-Caspase-8-/-712 
Hoil-1-/- and n=3 for Mlkl-/-Caspase-8-/-Hoil-1-/- foetal livers) and P values from two-way ANOVA are 713 
reported. d, h, k Representative FACS profile of E13.5 foetal liver cells for the indicated haematopoietic 714 
populations (sample size specified in (e-g, i, j)). e, f, j Total cell number of the different haematopoietic 715 
cell subsets in foetal liver cell suspensions from E13.5 embryos of the indicated genotypes gated as in 716 
(d), (h) and (k), respectively. Total number of multipotent progenitors (LSK and LK cells) (e), mature 717 
CD45+ blood cells, including granulocytes (GR-1+) and macrophages (F4-80+) (f) and myeloid 718 
progenitors (CMP, GMP and MEP) (j). Mean ± s.e.m. and P values from unpaired two-tailed t-tests are 719 
reported. g, i, Percentages of mature CD45+ leucocytes, GR-1+ and F4-80+ cells (g) and CMP, GMP and 720 
MEP (i). Mean ± s.e.m. and P values from unpaired two-tailed t-tests are reported. l, Differentiation of 721 
E13.5 foetal liver (c-KIT+) progenitors into CFU-granulocytes and macrophages (GM), burst forming 722 
units-erythrocyte (BFU-E) or and CFU-granulocyte, erythroid, macrophage, megakaryocyte (GEMM). 723 
Mean ± s.e.m. (n=2 foetal livers). m, Micrographs of differentiated macrophages (n=3 Ripk3-/-Caspase-724 
8-/-Hoil-1+/- and Ripk3-/-Caspase-8-/-Hoil-1-/-, n=5 Mlkl-/-Caspase-8-/-Hoil-1+/- and n=4 Mlkl-/-Caspase-8-725 
/-Hoil-1-/- foetal livers) and percentage viability of macrophages from E13.5 foetal liver cell suspensions 726 
from embryos of the indicated genotypes in the presence or absence of the indicated inhibitors as 727 
measured by Cell Titer Glo. Mean ± s.e.m. (n=3 Ripk3-/-Caspase-8-/-Hoil-1+/- and Ripk3-/-Caspase-8-/-728 
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Hoil-1-/-, n=5 Mlkl-/-Caspase-8-/-Hoil-1+/- and n=4 Mlkl-/-Caspase-8-/-Hoil-1-/-  foetal livers) and P values 729 
from two-way ANOVA are reported. o, MicroCT scan images of  Ripk3-/-Caspase-8-/-Hoil-1-/- embryos 730 
showing maximum intensity projections, with windowing applied to highlight vasculature (high 731 
contrast). No anatomical defects that would explain destruction of RBCs or poor distribution of blood 732 
to the peripheries were found (n=3 embryos). Left image: yellow star: distal aorta, green star: umbilical 733 
vessels and red star: descending thoracic aorta. Right image, yellow star: carotid artery, red star: 734 
descending thoracic aorta, white star: ductus arteriosus, blue star: ascending thoracic aorta. p, 735 
Representative FACS profile of a pool of three E11.5 dorsal aortas, containing the AGM region, per 736 
indicated genotype and quantification. This experiment was performed once with 3 embryos per 737 
genotype.  738 
 739 
Extended data Figure 9. Concomitant deletion of RIPK1 prevents embryonic lethality of Ripk3-/-740 
Caspase-8-/-Hoil-1-/- mice.  741 
a, Kaplan-Meier plot of mouse survival (n=17 for Ripk1-/ Ripk3-/-Caspase-8-/-Hoip-/- and n=2 for Ripk+/-742 
Ripk3-/-Caspase-8-/-Hoip-/- mice). b, Quantification of genotypes of animals obtained from inter-crosses 743 
of Ripk1+/-Hoil-1+/- mice. For simplicity not all possible genotypes are represented. c, Percentage 744 
viability of macrophages from E13.5 foetal liver cell suspensions from embryos of the indicated 745 
genotypes as measured by Cell Titer Glo. Mean ± s.e.m. (n=5 foetal livers/genotype) are reported and 746 
results were analysed with unpaired two-tailed t-tests. d, Cytokine arrays from Ripk3-/-Caspase-8-/-Hoil-747 
1+/- and Ripk3-/-Caspase-8-/-Hoil-1-/- embryos (left panels) and table listing the altered cytokines (right 748 
panel). Red squares highlight the differences (n=1 for each genotype). For gel source data, see 749 
Supplementary Figure 1. e, Cytokine analysis in homogenates from embryos of the indicated genotypes. 750 
Mean ± s.e.m. (n=3 embryos/genotype) and P values from one-way ANOVA are reported. f, 751 
Representative images of E16.5 embryos from control mothers or mothers fed with the RIPK1 kinase 752 
inhibitor GSK’457A from mating and throughout gestation (embryos treated with GSK'457A n=5 for 753 
Ripk3-/-Caspase-8-/-Hoil-1+/- and n=7 Ripk3-/-Caspase-8+/-Hoil-1-/- and n=3 for Ripk3-/-Caspase-8-/-Hoil-754 
1-/-). Scale bar: 5 mm. 755 
Extended data Figure 10. Schematic representation of findings in this study 756 
a, Diagram indicating extent of viability and phenotypes of single, double, triple and quadruple 757 
knockout mice. Red lines indicate cell death and loss of yolk sac vascularisation phenotype. Green line 758 
indicates mild cell death phenotype without loss of yolk sac vascularisation. Asterisk (*) indicates that 759 
heart defects were observed. b, Proposed model of LUBAC function during embryogenesis. At mid-760 
gestation (left panel), LUBAC maintains vascular tissue integrity by preventing aberrant TNF/LT-α-761 
mediated Caspase-8- and RIPK3/MLKL-induced cell death. At late gestation, LUBAC is not only 762 
required to prevent aberrant cell death but also to prevent severe defects in haematopoiesis that are 763 
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driven by RIPK1 but can be prevented by RIPK3 (middle panel). Genetic ablation of LUBAC and of 764 
different components of the cell death machinery indicates that (right panel): 1) in the absence of 765 
LUBAC, Caspase-8 and RIPK3, RIPK1 provokes lethality most likely by depleting multipotent 766 
progenitors in the haematopoietic compartment; 2) in the absence of Caspase-8 and MLKL, cell death 767 
induced by loss of LUBAC is prevented and RIPK3 is present to exert its protective role on foetal 768 
haematopoiesis by precluding aberrant RIPK1 signalling; and 3) in the absence of Caspase-8 and 769 
RIPK3, the presence of LUBAC is sufficient to prevent RIPK1 from causing severe defects in 770 
haematopoiesis and lethality since Ripk3-/-Caspase-8-/- mice are viable15,16,23. This indicates that RIPK3 771 
and LUBAC can compensate for each other to block aberrant RIPK1 signalling.  772 
 773 
